Pancreatic Cancer Research

ResearcherActive in the last 2 years

Thomas Charles King

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0006-8581-5824; OpenAlex author ID A5002589756. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
30
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: 4 papers · 2026: 2 papers

Papers 7

  1. Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1053/j.gastro.2025.08.034↗
  2. The PancreaSure Multianalyte Blood Test Performs Well at Distinguishing Early-Stage Pancreatic Ductal Adenocarcinoma from High-Risk Controls: A Retrospective S… Co-author DOI 10.3390/jcm15197355↗
  3. Biomarker Discovery for Early Detection of Pancreatic Ductal Adenocarcinoma (PDAC) Using Multiplex Proteomics Technology. Co-author DOI 10.1021/acs.jproteome.4c00752↗
  4. A High Performing Biomarker Signature for Detecting Early-Stage Pancreatic Ductal Adenocarcinoma in High-Risk Individuals. Co-author DOI 10.3390/cancers17111866↗
  5. Confirmatory Clinical Validation of a Serum-Based Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/curroncol32110638↗
  6. Analytical Validation of a Serum Biomarker Signature for Detection of Early-Stage Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/diagnostics15243177↗
  7. Detection of Early-Stage Pancreatic Ductal Adenocarcinoma From Blood Samples: Results of a Multiplex Biomarker Signature Validation Study. Last author DOI 10.14309/ctg.0000000000000468↗

Closest collaborators

The 25 strongest of 30 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Norma Alonzo Palma · 6 shared papers, 2025–2026 · strength 1.53
  2. Lisa A. Ford · 5 shared papers, 2025–2026 · strength 1.27
  3. Randall E. Brand · 5 shared papers, 2022–2026 · strength 1.10
  4. Erkut Hasan Borazanci · 3 shared papers, 2025–2026 · strength 0.73
  5. Bryson W. Katona · 3 shared papers, 2022–2026 · strength 0.59
  6. Aimee Lee Lucas · 3 shared papers, 2022–2026 · strength 0.59
  7. Patricio Marcelo Polanco · 2 shared papers, 2025–2026 · strength 0.51
  8. Alcibiade Athanasiou · 2 shared papers, 2025 · strength 0.50
  9. Ralph Schiess · 2 shared papers, 2025 · strength 0.50
  10. Rosalie C. Sears · 2 shared papers, 2026 · strength 0.49
  11. Sonia S. Kupfer · 2 shared papers, 2026 · strength 0.49
  12. Walter Gwang-Up Park · 2 shared papers, 2026 · strength 0.49
  13. Salvatore Paiella · 2 shared papers, 2026 · strength 0.49
  14. Fay Kastrinos · 2 shared papers, 2026 · strength 0.49
  15. Jose Gilberto Trevino · 2 shared papers, 2025–2026 · strength 0.47
  16. Diane M. Simeone · 2 shared papers, 2025–2026 · strength 0.45
  17. Robyn Pescatore · 1 shared paper, 2025 · strength 0.30
  18. Tamas Gonda · 1 shared paper, 2026 · strength 0.26
  19. Tamas A. Gonda · 1 shared paper, 2025 · strength 0.25
  20. Evan Scott Glazer · 1 shared paper, 2025 · strength 0.25
  21. Jessica N. Everett · 1 shared paper, 2026 · strength 0.22
  22. Eli Marie Grindedal · 1 shared paper, 2026 · strength 0.22
  23. Raymond Couric Wadlow · 1 shared paper, 2026 · strength 0.22
  24. George Zogopoulos · 1 shared paper, 2026 · strength 0.22
  25. Linda Dexlin Mellby · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.